Literature DB >> 3498887

Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans.

J Tschopp1, D Masson.   

Abstract

The complement components (C6, C7, C8 and C9) implicated in the lysis of target cells and the pore-forming, lytic protein from cytotoxic T-lymphocytes and NK-cells, perforin, contain an amino acid sequence which is highly homologous to a repeat unit identified in the LDL-receptor (Tschopp et al., 1986, Nature, 322, 831-834). The domain of the LDL-receptor, which is thought to interact with a positively charged segment of its ligands apoprotein B and E, is rich in cysteine residues and contains a cluster of negative charges. We show that the negatively charged molecules suramin and glycosaminoglycans, the positively charged peptides protamine and polylysine, all of which are known to abolish binding of LDL to its receptor (Goldstein et al., 1985, A. Rev. cell. Biol., 1, 1-39) inhibit the lytic activities of C6, C7, C8, C9 and perforin. Moreover, these negatively charged molecules are potent inhibitors of cytolytic T-lymphocyte-mediated lysis of target cells, suggesting a functionally crucial role for perforin in cell-mediated cytolysis. We propose that the negatively charged, cysteine-rich domain of these complement proteins and perforin interacts with an as yet unidentified positively charged segment of its ligand in a manner analogous to the LDL-LDL receptor interaction. Homologous cysteine-rich domains in functionally unrelated proteins may therefore be functionally conserved as ideal rigid interaction domains with the conserved cysteine residues as framework. Specificity of the domain for its ligand would be conferred by the non-conserved amino acid residues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498887     DOI: 10.1016/0161-5890(87)90002-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

Authors:  J A Trapani
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

2.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

3.  Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.

Authors:  T Kataoka; K Togashi; H Takayama; K Takaku; K Nagai
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Identification of hemolytic granules isolated from human myocardial cells.

Authors:  Y Kawamoto; T Hanaichi; M Naito; A Miyama
Journal:  Experientia       Date:  1990-05-15

5.  Small angle neutron scattering studies of C8 and C9 and their interactions in solution.

Authors:  A F Esser; N M Thielens; G Zaccai
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

6.  Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.

Authors:  L Milis; C A Morris; M C Sheehan; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  Complement inhibition by human vitronectin involves non-heparin binding domains.

Authors:  M Sheehan; C A Morris; B A Pussell; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

8.  Inhibition of the alternative pathway of complement by glomerular chondroitin sulphate proteoglycan.

Authors:  R J Quigg
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

9.  A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.

Authors:  M Ling; S J Piddlesden; B P Morgan
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway.

Authors:  C H Bird; V R Sutton; J Sun; C E Hirst; A Novak; S Kumar; J A Trapani; P I Bird
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.